Rosita L. ten Berge

Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?

Bellinda A. Bladergroen, Chris J.L.M. Meijer, Rosita L. ten Berge et al. · Blood · 2002 · 154 citations · Full text

Medicine, Immunology, Oncology +17

Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma

Rosita L. ten Berge, Chris J.L.M. Meijer, Danny F. Dukers et al. · Blood · 2002 · 121 citations · Full text

Life Sciences, Oncology, Pathology +17

ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination

Rosita L. ten Berge · Journal of Clinical Pathology · 2000 · 106 citations · Full text

Medicine, Oncology, Pathology +15

ALK‐negative anaplastic large‐cell lymphoma demonstrates similar poor prognosis to peripheral T‐cell lymphoma, unspecified

Rosita L. ten Berge, Peter C. de Bruin, Joost J. Oudejans et al. · Histopathology · 2003 · 104 citations · Full text

Medicine, Oncology, Pathology +16

Adverse Effects of Activated Cytotoxic T Lymphocytes on the Clinical Outcome of Nodal Anaplastic Large Cell Lymphoma

Rosita L. ten Berge, Danny F. Dukers, Joost J. Oudejans et al. · Blood · 1999 · 56 citations

Life Sciences, Immunology, Oncology +11